Dual-targeted nanomedicines for enhanced tumor treatment
| Autor: | Zhiyuan Zhong, Yaqin Zhu, Jan Feijen |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Biomedical Engineering Pharmaceutical Science Bioengineering Tumor cells 02 engineering and technology Tumor targeted 03 medical and health sciences Targeting efficacy General Materials Science Dual-ligand Targeting ligands Tumor microenvironment Tumor therapy Cell-penetrating peptides Receptor-mediated endocytosis 021001 nanoscience & nanotechnology n/a OA procedure 030104 developmental biology Nanomedicine Cancer research Tumor-targeted delivery 0210 nano-technology Biotechnology |
| Zdroj: | Nano today. 18:65-85 |
| ISSN: | 1748-0132 |
| Popis: | Based on the overexpression of specific receptors on tumor cells, active targeting nanomedicines have been developed with the ability to efficiently deliver imaging agents in the tumor area or anticancer drugs into tumor cells via receptor-mediated endocytosis. Nevertheless, the efficacy of single-ligand nanomedicines is still limited due to the complexity of the tumor microenvironment. In recent years, dual-ligand nanomedicines have attracted a lot of interest, because these nanomedicines endowed with versatile functions, have the potential to improve the efficacy of tumor-targeted delivery. In this review, an overview of various dual-ligand nanomedicines for tumor targeted therapy will be presented, the role of cell penetrating peptides in combination with targeting ligands will be discussed and factors that affect the targeting efficacy of dual-ligand nanomedicines will be evaluated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect